Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4594)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2013 (publication date) through May 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim E, Bressler B, Schaeffer DF, Yoshida EM. Severe cholestasis due to adalimumab in a Crohn’s disease patient. World J Hepatol 2013; 5(10): 592-595 [PMID: 24179620 DOI: 10.4254/wjh.v5.i10.592] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i10/592.htm |
| Number | Citing Articles |
| 1 |
Joshua B. French, Maurizio Bonacini, Marwan Ghabril, David Foureau, Herbert L. Bonkovsky. Hepatotoxicity Associated with the Use of Anti-TNF-α Agents. Drug Safety 2016; 39(3): 199 doi: 10.1007/s40264-015-0366-9
|
| 2 |
Robert Hirten, Keith Sultan, Ashby Thomas, David E Bernstein. Hepatic manifestations of non-steroidal inflammatory bowel disease therapy. World Journal of Hepatology 2015; 7(27): 2716-2728 doi: 10.4254/wjh.v7.i27.2716
|
| 3 |
Nicholas L Harrison, Freya Hepworth-Lloyd, Patrick Briggs, James Melling. Haemorrhagic cholecystitis in a young patient, complicated by gallbladder perforation and choledocholithiasis. BMJ Case Reports 2023; 16(10): e257389 doi: 10.1136/bcr-2023-257389
|
| 4 |
Natalia Nedelkopoulou, Babu Vadamalayan, Diego Vergani, Giorgina Mieli‐Vergani. Anti‐TNFα Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2018; 66(1): 100 doi: 10.1097/MPG.0000000000001759
|
| 5 |
Lucy Shamberg, Haleh Vaziri. Hepatotoxicity of Inflammatory Bowel Disease Medications. Journal of Clinical Gastroenterology 2018; 52(8): 674 doi: 10.1097/MCG.0000000000001084
|
| 6 |
Sophie Restellini, Olivier Chazouillères, Jean‐Louis Frossard. Hepatic manifestations of inflammatory bowel diseases. Liver International 2017; 37(4): 475 doi: 10.1111/liv.13265
|
| 7 |
Beverley Kok, Erica L. W. Lester, William M. Lee, A. James Hanje, R. Todd Stravitz, Safwat Girgis, Vaishali Patel, Joshua R. Peck, Christopher Esber, Constantine J. Karvellas. Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review. Digestive Diseases and Sciences 2018; 63(6): 1654 doi: 10.1007/s10620-018-5023-6
|
| 8 |
My-Linh Tran-Minh, Paula Sousa, Marianne Maillet, Matthieu Allez, Jean-Marc Gornet. Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease. World Journal of Hepatology 2017; 9(13): 613-626 doi: 10.4254/wjh.v9.i13.613
|
| 9 |
Mahmoud Mahfouz, Paul Martin, Andres F. Carrion. Hepatic Complications of Inflammatory Bowel Disease. Clinics in Liver Disease 2019; 23(2): 191 doi: 10.1016/j.cld.2018.12.003
|